Hopman Mark sold BBNX
October 14, 2026 · Form 4 insider transaction
Hopman Mark sold 775 shares of Beta Bionics, Inc. at $17.35 per share, a transaction worth $13.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
775
Price
$17.35
Total value
$13.4K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 14, 2026
Filing dateOctober 16, 2026
Shares owned after55,334
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.; The weighted average sale price for the transaction reported was $17.35 and the range of prices were between $17.35 and $18.3499. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.